Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hermann

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
European Journal of Endocrinology|December 4, 2003
Androgen receptor gene exon 1 CAG repeat polymorphism in Finnish patients with childhood-onset type 1 diabetesZsofia Gombos, Robert Hermann, Riitta Veijola, et al.
British Journal of Clinical Pharmacology|February 24, 2012
Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal sprayHartmut Derendorf, Ullrich Munzel, Ursula Petzold, et al.
Journal of Clinical Pharmacology|February 11, 2005
Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal diseaseJens Teichert, Tina Tuemmers, Harald Achenbach, et al.
Clinical Pharmacokinetics|August 2, 2018
Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple SclerosisRobert Hermann, Mats O Karlsson, Ana M Novakovic, et al.
Arzneimittel-Forschung|April 23, 2003
Azelastine eye drops in the treatment of perennial allergic conjunctivitisOzod Nazarov, Ursula Petzold, Hans Haase, et al.
Clinical Pharmacokinetics|July 11, 2018
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple SclerosisRobert Hermann, Mats O Karlsson, Ana M Novakovic, et al.
Biopharmaceutics & Drug Disposition|October 26, 2012
Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjectsSonja Krösser, Anne Marquet, Dieter Gallemann, et al.
Journal of Clinical Pharmacology|March 18, 2003
Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal womenNelamangala V Nagaraja, Birgit Pechstein, Katharina Erb, et al.
Clinical Pharmacokinetics|August 26, 2021
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of CladribineRobert Hermann, Peter Krajcsi, Markus Fluck, et al.
Journal of Clinical Pharmacology|September 22, 2006
Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjectsBernhard Hauns, Robert Hermann, Andreas Hünnemeyer, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
European Journal of Endocrinology|December 4, 2003
Androgen receptor gene exon 1 CAG repeat polymorphism in Finnish patients with childhood-onset type 1 diabetesZsofia Gombos, Robert Hermann, Riitta Veijola, et al.
British Journal of Clinical Pharmacology|February 24, 2012
Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal sprayHartmut Derendorf, Ullrich Munzel, Ursula Petzold, et al.
Journal of Clinical Pharmacology|February 11, 2005
Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal diseaseJens Teichert, Tina Tuemmers, Harald Achenbach, et al.
Clinical Pharmacokinetics|August 2, 2018
Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple SclerosisRobert Hermann, Mats O Karlsson, Ana M Novakovic, et al.
Arzneimittel-Forschung|April 23, 2003
Azelastine eye drops in the treatment of perennial allergic conjunctivitisOzod Nazarov, Ursula Petzold, Hans Haase, et al.
Clinical Pharmacokinetics|July 11, 2018
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple SclerosisRobert Hermann, Mats O Karlsson, Ana M Novakovic, et al.
Biopharmaceutics & Drug Disposition|October 26, 2012
Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjectsSonja Krösser, Anne Marquet, Dieter Gallemann, et al.
Journal of Clinical Pharmacology|March 18, 2003
Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal womenNelamangala V Nagaraja, Birgit Pechstein, Katharina Erb, et al.
Clinical Pharmacokinetics|August 26, 2021
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of CladribineRobert Hermann, Peter Krajcsi, Markus Fluck, et al.
Journal of Clinical Pharmacology|September 22, 2006
Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjectsBernhard Hauns, Robert Hermann, Andreas Hünnemeyer, et al.
Pageof 12